GlassScriptPhysician profile
Russell Howard Silver
NPI 1053377796
$34,325.53
in general payments reported to CMS, 2019-2025
16 companies · $31.33 in 2025
The $31.33 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $4,195 · 2021: $3,302 · 2022: $742 · 2023: $766 · 2024: $441 · 2025: $31.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $23,014.86 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $7,308.94 | 2019-2025 | Relistor |
| Redhill Biopharma INC. | $901.08 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $781.26 | 2019-2022 | |
| Daiichi Sankyo INC. | $595.95 | 2019 | |
| Pfizer INC. | $391.56 | 2019-2023 | |
| Collegium Pharmaceutical, INC. | $263.33 | 2019 | |
| Fidia Pharma USA INC. | $191.78 | 2019-2022 | |
| Curonix LLC | $164.46 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceutical Holding Company LTD. | $157.44 | 2022 | |
| Forte Bio-Pharma LLC | $157.28 | 2023-2024 | Prolate, Nalocet |
| Assertio Therapeutics, INC. | $141.11 | 2019 | |
| Depuy Synthes Sales INC. | $107.71 | 2019-2022 | |
| Almatica Pharma LLC | $99.48 | 2023 | Gralise |
| Hikma Pharmaceuticals USA | $33.81 | 2023 | Kloxxado |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.